Zhaoke Ophthalmology Limited (HKG:6622)
Hong Kong · Delayed Price · Currency is HKD 2.910
-0.020 (-0.68%)
At close: Mar 27, 2026
Zhaoke Ophthalmology Market Cap
Zhaoke Ophthalmology has a market cap or net worth of 1.6 billion as of March 27, 2026. Its market cap has increased by 38.57% in one year.
Market Cap
1.60B
Enterprise Value
853.00M
Revenue
35.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.91
Market Cap Chart
Since April 29, 2021, Zhaoke Ophthalmology's market cap has decreased from 7.66B to 1.60B, a decrease of -79.16%. That is a compound annual growth rate of -27.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 1.60B | -1.55% |
| Dec 31, 2025 | 1.62B | 147.49% |
| Dec 31, 2024 | 655.37M | -69.49% |
| Dec 29, 2023 | 2.15B | 30.79% |
| Dec 30, 2022 | 1.64B | -46.83% |
| Dec 31, 2021 | 3.09B | -59.69% |
| Apr 29, 2021 | 7.66B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mabpharm | 2.35B |
| Frontage Holdings | 2.21B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 2.02B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 2.00B |
| HighTide Therapeutics | 1.78B |
| Cutia Therapeutics | 1.73B |
| CANbridge Pharmaceuticals | 1.55B |
| Immunotech Biopharm | 1.54B |